-
1
-
-
84889639581
-
-
Alzheimer's Disease Association, on line source
-
Gaugler J, James B, Johnson T, Scholz K, Weuve J. Alzheimer's Disease Facts and Figures 2013 2013, Alzheimer's Disease Association, on line source: http://www.alz.org/downloads/facts_figures_2013.pdf.
-
(2013)
Alzheimer's Disease Facts and Figures 2013
-
-
Gaugler, J.1
James, B.2
Johnson, T.3
Scholz, K.4
Weuve, J.5
-
2
-
-
84864232926
-
Disease modifying drugs targeting beta-amyloid
-
10.1177/1533317512452034, 22815077
-
Ozudogru SN, Lippa CF. Disease modifying drugs targeting beta-amyloid. Am J Alzheimers Dis Other Demen 2012, 27:296-300. 10.1177/1533317512452034, 22815077.
-
(2012)
Am J Alzheimers Dis Other Demen
, vol.27
, pp. 296-300
-
-
Ozudogru, S.N.1
Lippa, C.F.2
-
3
-
-
84862315328
-
Active immunotherapy for Alzheimer's disease
-
10.1016/S1474-4422(12)70136-9, 3560289, 22677257
-
Wisniewski T. Active immunotherapy for Alzheimer's disease. Lancet Neurol 2012, 11:571-572. 10.1016/S1474-4422(12)70136-9, 3560289, 22677257.
-
(2012)
Lancet Neurol
, vol.11
, pp. 571-572
-
-
Wisniewski, T.1
-
4
-
-
77951782384
-
Current therapeutic targets for the treatment of Alzheimer's disease
-
10.1586/ern.10.29, 20420492
-
Grill JD, Cummings JL. Current therapeutic targets for the treatment of Alzheimer's disease. Expert Rev Neurother 2010, 10:711-728. 10.1586/ern.10.29, 20420492.
-
(2010)
Expert Rev Neurother
, vol.10
, pp. 711-728
-
-
Grill, J.D.1
Cummings, J.L.2
-
5
-
-
78650210590
-
Immunotherapy for Alzheimer's disease
-
10.1111/j.1365-2796.2010.02315.x, 3074967, 21158978
-
Morgan D. Immunotherapy for Alzheimer's disease. J Intern Med 2011, 269:54-63. 10.1111/j.1365-2796.2010.02315.x, 3074967, 21158978.
-
(2011)
J Intern Med
, vol.269
, pp. 54-63
-
-
Morgan, D.1
-
6
-
-
84863337843
-
Alzheimer mechanisms and therapeutic strategies
-
10.1016/j.cell.2012.02.040, 3319071, 22424230
-
Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012, 148:1204-1222. 10.1016/j.cell.2012.02.040, 3319071, 22424230.
-
(2012)
Cell
, vol.148
, pp. 1204-1222
-
-
Huang, Y.1
Mucke, L.2
-
7
-
-
84860215480
-
Correlation of Alzheimer's disease neuropathologic changes with cognitive status: a review of the literature
-
10.1097/NEN.0b013e31825018f7, 3560290, 22487856
-
Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns N, Davies P, Tredici KD, Duyckaerts C, Frosch MP, Hof PR, Hulette C, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kovari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee A, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG. Correlation of Alzheimer's disease neuropathologic changes with cognitive status: a review of the literature. J Neuropath Exp Neurol 2012, 71:362-381. 10.1097/NEN.0b013e31825018f7, 3560290, 22487856.
-
(2012)
J Neuropath Exp Neurol
, vol.71
, pp. 362-381
-
-
Nelson, P.T.1
Alafuzoff, I.2
Bigio, E.H.3
Bouras, C.4
Braak, H.5
Cairns, N.6
Davies, P.7
Tredici, K.D.8
Duyckaerts, C.9
Frosch, M.P.10
Hof, P.R.11
Hulette, C.12
Hyman, B.T.13
Iwatsubo, T.14
Jellinger, K.A.15
Jicha, G.A.16
Kovari, E.17
Kukull, W.A.18
Leverenz, J.B.19
Love, S.20
Mackenzie, I.R.21
Mann, D.M.22
Masliah, E.23
McKee, A.24
Montine, T.J.25
Morris, J.C.26
Schneider, J.A.27
Sonnen, J.A.28
Thal, D.R.29
Trojanowski, J.Q.30
Troncoso, J.C.31
Wisniewski, T.32
Woltjer, R.L.33
Beach, T.G.34
more..
-
8
-
-
84876925888
-
The case for soluble Abeta oligomers as a drug target in Alzheimer's disease
-
10.1016/j.tips.2013.03.002, 23582316
-
Hefti F, Goure WF, Jerecic J, Iverson KS, Walicke PA, Krafft GA. The case for soluble Abeta oligomers as a drug target in Alzheimer's disease. Trends Pharmacol Sci 2013, 34:261-266. 10.1016/j.tips.2013.03.002, 23582316.
-
(2013)
Trends Pharmacol Sci
, vol.34
, pp. 261-266
-
-
Hefti, F.1
Goure, W.F.2
Jerecic, J.3
Iverson, K.S.4
Walicke, P.A.5
Krafft, G.A.6
-
10
-
-
84874638938
-
Prions, prionoids and pathogenic proteins in Alzheimer disease
-
10.4161/pri.23061, 3609051, 23208281
-
Ashe KH, Aguzzi A. Prions, prionoids and pathogenic proteins in Alzheimer disease. Prion 2013, 7:55-59. 10.4161/pri.23061, 3609051, 23208281.
-
(2013)
Prion
, vol.7
, pp. 55-59
-
-
Ashe, K.H.1
Aguzzi, A.2
-
11
-
-
77950459664
-
Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models
-
10.1007/s00429-009-0236-2, 3124148, 20012091
-
Wisniewski T, Boutajangout A. Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models. Brain Struct Funct 2010, 214:201-218. 10.1007/s00429-009-0236-2, 3124148, 20012091.
-
(2010)
Brain Struct Funct
, vol.214
, pp. 201-218
-
-
Wisniewski, T.1
Boutajangout, A.2
-
12
-
-
34447630226
-
Is vaccination against transmissible spongiform encephalopathies feasible?
-
Wisniewski T, Chabalgoity JA, Goni F. Is vaccination against transmissible spongiform encephalopathies feasible?. OIE Sci Tech Rev 2007, 26:243-251.
-
(2007)
OIE Sci Tech Rev
, vol.26
, pp. 243-251
-
-
Wisniewski, T.1
Chabalgoity, J.A.2
Goni, F.3
-
13
-
-
84872730067
-
Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis - but what lies beyond?
-
10.1016/j.bcp.2012.11.014, 23178653
-
Mullane K, Williams M. Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis - but what lies beyond?. Biochem Pharmacol 2013, 85:289-305. 10.1016/j.bcp.2012.11.014, 23178653.
-
(2013)
Biochem Pharmacol
, vol.85
, pp. 289-305
-
-
Mullane, K.1
Williams, M.2
-
14
-
-
0033600228
-
A stop-codon mutation in the BRI gene associated with familial British dementia
-
10.1038/21637, 10391242
-
Vidal R, Frangione B, Rostagno A, Mead S, Revesz T, Plant G, Ghiso J. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999, 399:776-781. 10.1038/21637, 10391242.
-
(1999)
Nature
, vol.399
, pp. 776-781
-
-
Vidal, R.1
Frangione, B.2
Rostagno, A.3
Mead, S.4
Revesz, T.5
Plant, G.6
Ghiso, J.7
-
15
-
-
23944481823
-
Chromosome 13 dementias
-
10.1007/s00018-005-5092-5, 15968464
-
Rostagno A, Tomidokoro Y, Lashley T, Ng D, Plant G, Holton J, Frangione B, Revesz T, Ghiso J. Chromosome 13 dementias. Cell Mol Life Sci 2005, 62:1814-1825. 10.1007/s00018-005-5092-5, 15968464.
-
(2005)
Cell Mol Life Sci
, vol.62
, pp. 1814-1825
-
-
Rostagno, A.1
Tomidokoro, Y.2
Lashley, T.3
Ng, D.4
Plant, G.5
Holton, J.6
Frangione, B.7
Revesz, T.8
Ghiso, J.9
-
16
-
-
78149424228
-
Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease
-
10.1371/journal.pone.0013391, 2954195, 20967130
-
Goni F, Prelli F, Ji Y, Scholtzova H, Yang J, Sun Y, Liang FX, Kascsak R, Kascsak R, Mehta P, Wisniewski T. Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease. PLoS ONE 2010, 5:e13391. 10.1371/journal.pone.0013391, 2954195, 20967130.
-
(2010)
PLoS ONE
, vol.5
-
-
Goni, F.1
Prelli, F.2
Ji, Y.3
Scholtzova, H.4
Yang, J.5
Sun, Y.6
Liang, F.X.7
Kascsak, R.8
Kascsak, R.9
Mehta, P.10
Wisniewski, T.11
-
17
-
-
79960359900
-
Vaccines: chasing the dream
-
10.1038/475S18a, 21760578
-
Schnabel J. Vaccines: chasing the dream. Nature 2011, 475:S18-S19. 10.1038/475S18a, 21760578.
-
(2011)
Nature
, vol.475
-
-
Schnabel, J.1
-
18
-
-
2442594971
-
Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor
-
10.1074/jbc.M312946200, 14985348
-
Davis J, Xu F, Deane R, Romanov G, Previti ML, Zeigler K, Zlokovic BV, van Nostrand WE. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 2004, 279:20296-20306. 10.1074/jbc.M312946200, 14985348.
-
(2004)
J Biol Chem
, vol.279
, pp. 20296-20306
-
-
Davis, J.1
Xu, F.2
Deane, R.3
Romanov, G.4
Previti, M.L.5
Zeigler, K.6
Zlokovic, B.V.7
van Nostrand, W.E.8
-
19
-
-
0042697305
-
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction
-
10.1016/S0896-6273(03)00434-3, 12895417
-
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 2003, 39:409-421. 10.1016/S0896-6273(03)00434-3, 12895417.
-
(2003)
Neuron
, vol.39
, pp. 409-421
-
-
Oddo, S.1
Caccamo, A.2
Shepherd, J.D.3
Murphy, M.P.4
Golde, T.E.5
Kayed, R.6
Metherate, R.7
Mattson, M.P.8
Akbari, Y.9
LaFerla, F.M.10
-
20
-
-
85081459637
-
Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology
-
epub October 10
-
Liu S, Breitbart A, Sun Y, Mehta PD, Boutajangout A, Scholtzova H, Wisniewski T. Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology. J.Neurochem 2013, epub October 10.
-
(2013)
J.Neurochem
-
-
Liu, S.1
Breitbart, A.2
Sun, Y.3
Mehta, P.D.4
Boutajangout, A.5
Scholtzova, H.6
Wisniewski, T.7
-
21
-
-
25144486849
-
Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein
-
10.1016/S0002-9440(10)62993-8, 1603574, 16049335
-
Miao J, Xu F, Davis J, Otte-Holler I, Verbeek MM, van Nostrand WE. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 2005, 167:505-515. 10.1016/S0002-9440(10)62993-8, 1603574, 16049335.
-
(2005)
Am J Pathol
, vol.167
, pp. 505-515
-
-
Miao, J.1
Xu, F.2
Davis, J.3
Otte-Holler, I.4
Verbeek, M.M.5
van Nostrand, W.E.6
-
22
-
-
79955585471
-
Blocking the apolipoprotein E/amyloid β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice
-
3132897, 21239853
-
Yang J, Ji Y, Mehta P, Bates KA, Sun Y, Wisniewski T. Blocking the apolipoprotein E/amyloid β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice. J Alzheimers Dis 2011, 24:269-285. 3132897, 21239853.
-
(2011)
J Alzheimers Dis
, vol.24
, pp. 269-285
-
-
Yang, J.1
Ji, Y.2
Mehta, P.3
Bates, K.A.4
Sun, Y.5
Wisniewski, T.6
-
23
-
-
33845484383
-
Blocking the apolipoprotein E/amyloid β interaction reduces the parenchymal and vascular amyloid-b deposition and prevents memory deficit in AD transgenic mice
-
10.1073/pnas.0604011103, 1654132, 17116874
-
Sadowski M, Pankiewicz J, Scholtzova H, Mehta P, Prelli F, Quartermain D, Wisniewski T. Blocking the apolipoprotein E/amyloid β interaction reduces the parenchymal and vascular amyloid-b deposition and prevents memory deficit in AD transgenic mice. Proc Natl Acad Sci USA 2006, 103:18787-18792. 10.1073/pnas.0604011103, 1654132, 17116874.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 18787-18792
-
-
Sadowski, M.1
Pankiewicz, J.2
Scholtzova, H.3
Mehta, P.4
Prelli, F.5
Quartermain, D.6
Wisniewski, T.7
-
24
-
-
60849137841
-
Induction of Toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease related pathology
-
10.1523/JNEUROSCI.5715-08.2009, 2699573, 19211891
-
Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC, Mehta PD, Spinner DS, Wisniewski T. Induction of Toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease related pathology. J Neurosci 2009, 29:1846-1854. 10.1523/JNEUROSCI.5715-08.2009, 2699573, 19211891.
-
(2009)
J Neurosci
, vol.29
, pp. 1846-1854
-
-
Scholtzova, H.1
Kascsak, R.J.2
Bates, K.A.3
Boutajangout, A.4
Kerr, D.J.5
Meeker, H.C.6
Mehta, P.D.7
Spinner, D.S.8
Wisniewski, T.9
-
25
-
-
0028593606
-
Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
-
10.1002/jnr.490390607, 7534834
-
Otvos L, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994, 39:669-673. 10.1002/jnr.490390607, 7534834.
-
(1994)
J Neurosci Res
, vol.39
, pp. 669-673
-
-
Otvos, L.1
Feiner, L.2
Lang, E.3
Szendrei, G.I.4
Goedert, M.5
Lee, V.M.6
-
26
-
-
0028946744
-
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
-
10.1016/0304-3940(95)11484-E, 7624036
-
Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995, 189:167-169. 10.1016/0304-3940(95)11484-E, 7624036.
-
(1995)
Neurosci Lett
, vol.189
, pp. 167-169
-
-
Goedert, M.1
Jakes, R.2
Vanmechelen, E.3
-
27
-
-
0034521191
-
Lower cognitive performance of older football players possessing apolipoprotein E epsilon4
-
Kutner KC, Erlanger DM, Tsai J, Jordan B, Relkin NR. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4. Neurosurgery 2000, 47:651-657.
-
(2000)
Neurosurgery
, vol.47
, pp. 651-657
-
-
Kutner, K.C.1
Erlanger, D.M.2
Tsai, J.3
Jordan, B.4
Relkin, N.R.5
-
28
-
-
24644438615
-
Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics
-
10.1097/01.jnen.0000178444.33972.e0, 16141783
-
Morgan D, Gordon MN, Tan J, Wilcock D, Rojiani AM. Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol 2005, 64:743-753. 10.1097/01.jnen.0000178444.33972.e0, 16141783.
-
(2005)
J Neuropathol Exp Neurol
, vol.64
, pp. 743-753
-
-
Morgan, D.1
Gordon, M.N.2
Tan, J.3
Wilcock, D.4
Rojiani, A.M.5
-
29
-
-
57049085109
-
A NMDA receptor antagonist leads to behavioral improvement and amyloid reduction in Alzheimer's disease model transgenic mice shown by micro-magnetic resonance imaging
-
10.1002/jnr.21713, 2723808, 18615702
-
Scholtzova H, Wadghiri YZ, Douadi M, Sigurdsson EM, Li Y, Quartermain D, Banerjee P, Wisniewski T. A NMDA receptor antagonist leads to behavioral improvement and amyloid reduction in Alzheimer's disease model transgenic mice shown by micro-magnetic resonance imaging. J Neurosci Res 2008, 86:2784-2791. 10.1002/jnr.21713, 2723808, 18615702.
-
(2008)
J Neurosci Res
, vol.86
, pp. 2784-2791
-
-
Scholtzova, H.1
Wadghiri, Y.Z.2
Douadi, M.3
Sigurdsson, E.M.4
Li, Y.5
Quartermain, D.6
Banerjee, P.7
Wisniewski, T.8
-
30
-
-
33644809258
-
Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease
-
10.1002/mrm.20810, 16470593
-
Dhenain M, Delatour B, Walczak C, Volk A. Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease. Magn Reson Med 2006, 55:687-693. 10.1002/mrm.20810, 16470593.
-
(2006)
Magn Reson Med
, vol.55
, pp. 687-693
-
-
Dhenain, M.1
Delatour, B.2
Walczak, C.3
Volk, A.4
-
31
-
-
68349127365
-
Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice
-
10.1016/j.neuroscience.2009.05.071, 19500657
-
Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C, Arendash GW. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience 2009, 163:55-72. 10.1016/j.neuroscience.2009.05.071, 19500657.
-
(2009)
Neuroscience
, vol.163
, pp. 55-72
-
-
Sanchez-Ramos, J.1
Song, S.2
Sava, V.3
Catlow, B.4
Lin, X.5
Mori, T.6
Cao, C.7
Arendash, G.W.8
-
32
-
-
77956057086
-
Murine models of Alzheimer's disease and their use in developing immunotherapies
-
Wisniewski T, Sigurdsson EM. Murine models of Alzheimer's disease and their use in developing immunotherapies. Biochim Biophys Acta Mol Basis Dis 1802, 2010:847-859.
-
(1802)
Biochim Biophys Acta Mol Basis Dis
, vol.2010
, pp. 847-859
-
-
Wisniewski, T.1
Sigurdsson, E.M.2
-
33
-
-
0036175608
-
Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1 + APP mouse
-
10.1006/exnr.2001.7754, 11822882
-
Gordon MN, Holcomb LA, Jantzen PT, DiCarlo G, Wilcock D, Boyett KW, Connor K, Melachrino J, O'Callaghan JP, Morgan D. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1 + APP mouse. Exp Neurol 2002, 173:183-195. 10.1006/exnr.2001.7754, 11822882.
-
(2002)
Exp Neurol
, vol.173
, pp. 183-195
-
-
Gordon, M.N.1
Holcomb, L.A.2
Jantzen, P.T.3
DiCarlo, G.4
Wilcock, D.5
Boyett, K.W.6
Connor, K.7
Melachrino, J.8
O'Callaghan, J.P.9
Morgan, D.10
-
34
-
-
75649133191
-
Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's disease
-
10.1002/msj.20160, 3306842, 20101723
-
Lublin AL, Gandy S. Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's disease. Mt Sinai J Med 2010, 77:43-49. 10.1002/msj.20160, 3306842, 20101723.
-
(2010)
Mt Sinai J Med
, vol.77
, pp. 43-49
-
-
Lublin, A.L.1
Gandy, S.2
-
35
-
-
84876569513
-
Blocking the interaction between apolipoprotein E and Abeta reduces intraneuronal accumulation of Abeta and inhibits synaptic degeneration
-
10.1016/j.ajpath.2013.01.034, 23499462
-
Kuszczyk MA, Sanchez S, Pankiewicz J, Kim J, Duszczyk M, Guridi M, Asuni AA, Sullivan PM, Holtzman DM, Sadowski MJ. Blocking the interaction between apolipoprotein E and Abeta reduces intraneuronal accumulation of Abeta and inhibits synaptic degeneration. Am J Pathol 2013, 182:1750-1768. 10.1016/j.ajpath.2013.01.034, 23499462.
-
(2013)
Am J Pathol
, vol.182
, pp. 1750-1768
-
-
Kuszczyk, M.A.1
Sanchez, S.2
Pankiewicz, J.3
Kim, J.4
Duszczyk, M.5
Guridi, M.6
Asuni, A.A.7
Sullivan, P.M.8
Holtzman, D.M.9
Sadowski, M.J.10
-
36
-
-
77954835300
-
High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
-
10.1096/fj.09-150359, 20339023
-
Fukumoto H, Tokuda T, Kasai T, Ishigami N, Hidaka H, Kondo M, Allsop D, Nakagawa M. High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J 2010, 24:2716-2726. 10.1096/fj.09-150359, 20339023.
-
(2010)
FASEB J
, vol.24
, pp. 2716-2726
-
-
Fukumoto, H.1
Tokuda, T.2
Kasai, T.3
Ishigami, N.4
Hidaka, H.5
Kondo, M.6
Allsop, D.7
Nakagawa, M.8
-
37
-
-
81855211122
-
Biochemical and morphological characterization of the AbetaPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease
-
3327160, 21860086
-
Hunter JM, Bowers WJ, Maarouf CL, Mastrangelo MA, Daugs ID, Kokjohn TA, Kalback WM, Luehrs DC, Valla J, Beach TG, Roher AE. Biochemical and morphological characterization of the AbetaPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease. J Alzheimers Dis 2011, 27:361-376. 3327160, 21860086.
-
(2011)
J Alzheimers Dis
, vol.27
, pp. 361-376
-
-
Hunter, J.M.1
Bowers, W.J.2
Maarouf, C.L.3
Mastrangelo, M.A.4
Daugs, I.D.5
Kokjohn, T.A.6
Kalback, W.M.7
Luehrs, D.C.8
Valla, J.9
Beach, T.G.10
Roher, A.E.11
-
38
-
-
0034528382
-
Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13
-
Ghiso J, Vidal R, Rostagno A, Miravalle L, Holton JL, Mead S, Revesz T, Plant G, Frangione B. Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13. Molecular Basis of Dementia 2000, 920:84-92.
-
(2000)
Molecular Basis of Dementia
, vol.920
, pp. 84-92
-
-
Ghiso, J.1
Vidal, R.2
Rostagno, A.3
Miravalle, L.4
Holton, J.L.5
Mead, S.6
Revesz, T.7
Plant, G.8
Frangione, B.9
-
39
-
-
0142247606
-
PH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia
-
10.1016/j.jmb.2003.09.001, 14583196
-
Srinivasan R, Jones EM, Liu K, Ghiso J, Marchant RE, Zagorski MG. pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia. J Mol Biol 2003, 333:1003-1023. 10.1016/j.jmb.2003.09.001, 14583196.
-
(2003)
J Mol Biol
, vol.333
, pp. 1003-1023
-
-
Srinivasan, R.1
Jones, E.M.2
Liu, K.3
Ghiso, J.4
Marchant, R.E.5
Zagorski, M.G.6
-
40
-
-
0034700471
-
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
-
10.1038/35050110, 11140685
-
Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, George-Hyslop P, Westaway D. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000, 408:979-982. 10.1038/35050110, 11140685.
-
(2000)
Nature
, vol.408
, pp. 979-982
-
-
Janus, C.1
Pearson, J.2
McLaurin, J.3
Mathews, P.M.4
Jiang, Y.5
Schmidt, S.D.6
Chishti, M.A.7
Horne, P.8
Heslin, D.9
French, J.10
Mount, H.T.11
Nixon, R.A.12
Mercken, M.13
Bergeron, C.14
Fraser, P.E.15
George-Hyslop, P.16
Westaway, D.17
-
41
-
-
84984755327
-
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
-
10.1038/35050116, 11140686
-
Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000, 408:982-985. 10.1038/35050116, 11140686.
-
(2000)
Nature
, vol.408
, pp. 982-985
-
-
Morgan, D.1
Diamond, D.M.2
Gottschall, P.E.3
Ugen, K.E.4
Dickey, C.5
Hardy, J.6
Duff, K.7
Jantzen, P.8
DiCarlo, G.9
Wilcock, D.10
Connor, K.11
Hatcher, J.12
Hope, C.13
Gordon, M.14
Arendash, G.W.15
-
42
-
-
33750905657
-
Aβ derivative vaccination in alum adjuvant prevents amyloid deposition and does not cause brain microhemorrhages in Alzheimer's model mice
-
10.1111/j.1460-9568.2006.05149.x, 1779823, 17100841
-
Asuni A, Boutajangout A, Scholtzova H, Knudsen E, Li Y, Quartermain D, Frangione B, Wisniewski T, Sigurdsson EM. Aβ derivative vaccination in alum adjuvant prevents amyloid deposition and does not cause brain microhemorrhages in Alzheimer's model mice. Eur J Neurosci 2006, 24:2530-2542. 10.1111/j.1460-9568.2006.05149.x, 1779823, 17100841.
-
(2006)
Eur J Neurosci
, vol.24
, pp. 2530-2542
-
-
Asuni, A.1
Boutajangout, A.2
Scholtzova, H.3
Knudsen, E.4
Li, Y.5
Quartermain, D.6
Frangione, B.7
Wisniewski, T.8
Sigurdsson, E.M.9
-
43
-
-
84862652390
-
Alum adjuvant: some of the tricks of the oldest adjuvant
-
10.1099/jmm.0.038943-0, 22174375
-
Kool M, Fierens K, Lambrecht BN. Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol 2012, 61:927-934. 10.1099/jmm.0.038943-0, 22174375.
-
(2012)
J Med Microbiol
, vol.61
, pp. 927-934
-
-
Kool, M.1
Fierens, K.2
Lambrecht, B.N.3
-
44
-
-
84857558439
-
Immunotherapy for Alzheimer's disease: from anti-beta-amyloid to tau-based immunization strategies
-
10.2217/imt.11.170, 22339463
-
Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A. Immunotherapy for Alzheimer's disease: from anti-beta-amyloid to tau-based immunization strategies. Immunotherapy 2012, 4:213-238. 10.2217/imt.11.170, 22339463.
-
(2012)
Immunotherapy
, vol.4
, pp. 213-238
-
-
Panza, F.1
Frisardi, V.2
Solfrizzi, V.3
Imbimbo, B.P.4
Logroscino, G.5
Santamato, A.6
Greco, A.7
Seripa, D.8
Pilotto, A.9
-
45
-
-
58149385218
-
Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus
-
10.1523/JNEUROSCI.2692-08.2008, 2673049, 19118188
-
Puzzo D, Privitera L, Leznik E, Fa M, Staniszewski A, Palmeri A, Arancio O. Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 2008, 28:14537-14545. 10.1523/JNEUROSCI.2692-08.2008, 2673049, 19118188.
-
(2008)
J Neurosci
, vol.28
, pp. 14537-14545
-
-
Puzzo, D.1
Privitera, L.2
Leznik, E.3
Fa, M.4
Staniszewski, A.5
Palmeri, A.6
Arancio, O.7
-
46
-
-
69449090793
-
Beta-amyloid monomers are neuroprotective
-
10.1523/JNEUROSCI.1736-09.2009, 19710311
-
Giuffrida ML, Caraci F, Pignataro B, Cataldo S, De BP, Bruno V, Molinaro G, Pappalardo G, Messina A, Palmigiano A, Garozzo D, Nicoletti F, Rizzarelli E, Copani A. Beta-amyloid monomers are neuroprotective. J Neurosci 2009, 29:10582-10587. 10.1523/JNEUROSCI.1736-09.2009, 19710311.
-
(2009)
J Neurosci
, vol.29
, pp. 10582-10587
-
-
Giuffrida, M.L.1
Caraci, F.2
Pignataro, B.3
Cataldo, S.4
De, B.P.5
Bruno, V.6
Molinaro, G.7
Pappalardo, G.8
Messina, A.9
Palmigiano, A.10
Garozzo, D.11
Nicoletti, F.12
Rizzarelli, E.13
Copani, A.14
-
47
-
-
77949830350
-
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide
-
10.1371/journal.pone.0009505, 2831066, 20209079
-
Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS ONE 2010, 5:e9505. 10.1371/journal.pone.0009505, 2831066, 20209079.
-
(2010)
PLoS ONE
, vol.5
-
-
Soscia, S.J.1
Kirby, J.E.2
Washicosky, K.J.3
Tucker, S.M.4
Ingelsson, M.5
Hyman, B.6
Burton, M.A.7
Goldstein, L.E.8
Duong, S.9
Tanzi, R.E.10
Moir, R.D.11
-
48
-
-
33749614555
-
Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein
-
10.1001/archneur.63.10.1459, 17030663
-
Rosenmann H, Grigoriadis N, Karussis D, Boimel M, Touloumi O, Ovadia H, Abramsky O. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Arch Neurol 2006, 63:1459-1467. 10.1001/archneur.63.10.1459, 17030663.
-
(2006)
Arch Neurol
, vol.63
, pp. 1459-1467
-
-
Rosenmann, H.1
Grigoriadis, N.2
Karussis, D.3
Boimel, M.4
Touloumi, O.5
Ovadia, H.6
Abramsky, O.7
-
49
-
-
20944448555
-
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
-
Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Boada Rovira M, Forette F, Orgogozo JM. Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial. Neurol 2005, 64:1553-1562.
-
(2005)
Neurol
, vol.64
, pp. 1553-1562
-
-
Gilman, S.1
Koller, M.2
Black, R.S.3
Jenkins, L.4
Griffith, S.G.5
Fox, N.C.6
Eisner, L.7
Kirby, L.8
Boada Rovira, M.9
Forette, F.10
Orgogozo, J.M.11
-
50
-
-
75649143681
-
Vaccination as a therapeutic approach for Alzheimer's disease
-
10.1002/msj.20156, 3026780, 20101719
-
Wisniewski T, Boutajangout A. Vaccination as a therapeutic approach for Alzheimer's disease. Mt Sinai J Med 2010, 77:17-31. 10.1002/msj.20156, 3026780, 20101719.
-
(2010)
Mt Sinai J Med
, vol.77
, pp. 17-31
-
-
Wisniewski, T.1
Boutajangout, A.2
-
51
-
-
79960817113
-
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup
-
10.1016/j.jalz.2011.05.2351, 3693547, 21784348
-
Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement 2011, 7:367-385. 10.1016/j.jalz.2011.05.2351, 3693547, 21784348.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 367-385
-
-
Sperling, R.A.1
Jack, C.R.2
Black, S.E.3
Frosch, M.P.4
Greenberg, S.M.5
Hyman, B.T.6
Scheltens, P.7
Carrillo, M.C.8
Thies, W.9
Bednar, M.M.10
Black, R.S.11
Brashear, H.R.12
Grundman, M.13
Siemers, E.R.14
Feldman, H.H.15
Schindler, R.J.16
-
52
-
-
84885595750
-
Vascular alterations in PDAPP mice after anti-Abeta immunotherapy: Implications for amyloid-related imaging abnormalities
-
10.1016/j.jalz.2012.11.010, 23583235
-
Zago W, Schroeter S, Guido T, Khan K, Seubert P, Yednock T, Schenk D, Gregg KM, Games D, Bard F, Kinney GG. Vascular alterations in PDAPP mice after anti-Abeta immunotherapy: Implications for amyloid-related imaging abnormalities. Alzheimers Dement 2013, 9:S105-S115. 10.1016/j.jalz.2012.11.010, 23583235.
-
(2013)
Alzheimers Dement
, vol.9
-
-
Zago, W.1
Schroeter, S.2
Guido, T.3
Khan, K.4
Seubert, P.5
Yednock, T.6
Schenk, D.7
Gregg, K.M.8
Games, D.9
Bard, F.10
Kinney, G.G.11
-
53
-
-
76749152337
-
Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases
-
10.1159/000285518, 20173339
-
Jellinger KA. Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases. Neurodegener Dis 2010, 7:112-115. 10.1159/000285518, 20173339.
-
(2010)
Neurodegener Dis
, vol.7
, pp. 112-115
-
-
Jellinger, K.A.1
-
54
-
-
0036323445
-
Alzheimer disease and cerebrovascular pathology: an update
-
10.1007/s007020200068, 12111471
-
Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002, 109:813-836. 10.1007/s007020200068, 12111471.
-
(2002)
J Neural Transm
, vol.109
, pp. 813-836
-
-
Jellinger, K.A.1
-
55
-
-
14844327519
-
Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease
-
Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci 2005, 229-230:37-41.
-
(2005)
J Neurol Sci
, vol.229-230
, pp. 37-41
-
-
Jellinger, K.A.1
Attems, J.2
-
56
-
-
0037062566
-
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study
-
Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurol 2002, 58:1629-1634.
-
(2002)
Neurol
, vol.58
, pp. 1629-1634
-
-
Pfeifer, L.A.1
White, L.R.2
Ross, G.W.3
Petrovitch, H.4
Launer, L.J.5
-
57
-
-
34249780397
-
Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology
-
10.1016/j.jns.2007.01.013, 17306303
-
Attems J, Quass M, Jellinger KA, Lintner F. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. J Neurol Sci 2007, 257:49-55. 10.1016/j.jns.2007.01.013, 17306303.
-
(2007)
J Neurol Sci
, vol.257
, pp. 49-55
-
-
Attems, J.1
Quass, M.2
Jellinger, K.A.3
Lintner, F.4
-
58
-
-
7644219821
-
Amyloid angiopathy-related vascular cognitive impairment
-
10.1161/01.STR.0000143224.36527.44, 15459438
-
Greenberg SM, Gurol ME, Rosand J, Smith EE. Amyloid angiopathy-related vascular cognitive impairment. Stroke 2004, 35:2616-2619. 10.1161/01.STR.0000143224.36527.44, 15459438.
-
(2004)
Stroke
, vol.35
, pp. 2616-2619
-
-
Greenberg, S.M.1
Gurol, M.E.2
Rosand, J.3
Smith, E.E.4
-
59
-
-
0742306942
-
Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology - a pilot study
-
10.1007/s00401-003-0796-9, 14655019
-
Attems J, Jellinger KA. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology - a pilot study. Acta Neuropathol (Berl) 2004, 107:83-90. 10.1007/s00401-003-0796-9, 14655019.
-
(2004)
Acta Neuropathol (Berl)
, vol.107
, pp. 83-90
-
-
Attems, J.1
Jellinger, K.A.2
-
60
-
-
47149112621
-
Long term effects of Aβ42 immunization in Alzheimer's disease: immune response, plaque removal and clinical function
-
10.1016/S0140-6736(08)61075-2, 18640458
-
Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JAR. Long term effects of Aβ42 immunization in Alzheimer's disease: immune response, plaque removal and clinical function. Lancet 2008, 372:216-223. 10.1016/S0140-6736(08)61075-2, 18640458.
-
(2008)
Lancet
, vol.372
, pp. 216-223
-
-
Holmes, C.1
Boche, D.2
Wilkinson, D.3
Yadegarfar, G.4
Hopkins, V.5
Bayer, A.6
Jones, R.W.7
Bullock, R.8
Love, S.9
Neal, J.W.10
Zotova, E.11
Nicoll, J.A.R.12
-
61
-
-
77949300796
-
(11)C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
-
10.1016/S1474-4422(10)70043-0, 20189881
-
Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, de LIano SRM, Liu E, Koller M, Gregg KM, Schenk D, Black R, Grundman M. (11)C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol 2010, 9:363-372. 10.1016/S1474-4422(10)70043-0, 20189881.
-
(2010)
Lancet Neurol
, vol.9
, pp. 363-372
-
-
Rinne, J.O.1
Brooks, D.J.2
Rossor, M.N.3
Fox, N.C.4
Bullock, R.5
Klunk, W.E.6
Mathis, C.A.7
Blennow, K.8
Barakos, J.9
Okello, A.A.10
de Liano, S.R.M.11
Liu, E.12
Koller, M.13
Gregg, K.M.14
Schenk, D.15
Black, R.16
Grundman, M.17
-
62
-
-
84878769054
-
Therapeutic strategies for tau mediated neurodegeneration
-
10.1136/jnnp-2012-303144, 23085937
-
Yoshiyama Y, Lee VM, Trojanowski JQ. Therapeutic strategies for tau mediated neurodegeneration. J Neurol Neurosurg Psychiatry 2013, 84:784-795. 10.1136/jnnp-2012-303144, 23085937.
-
(2013)
J Neurol Neurosurg Psychiatry
, vol.84
, pp. 784-795
-
-
Yoshiyama, Y.1
Lee, V.M.2
Trojanowski, J.Q.3
-
63
-
-
84864497129
-
Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice
-
10.1186/1750-1326-7-37, 3476970, 22866920
-
Rasool S, Albay R, Martinez-Coria H, Breydo L, Wu J, Milton S, Misra S, Tran A, Pensalfini A, LaFerla F, Kayed R, Glabe CG. Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice. Mol Neurodegener 2012, 7:37. 10.1186/1750-1326-7-37, 3476970, 22866920.
-
(2012)
Mol Neurodegener
, vol.7
, pp. 37
-
-
Rasool, S.1
Albay, R.2
Martinez-Coria, H.3
Breydo, L.4
Wu, J.5
Milton, S.6
Misra, S.7
Tran, A.8
Pensalfini, A.9
LaFerla, F.10
Kayed, R.11
Glabe, C.G.12
-
64
-
-
84888015869
-
Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice
-
10.1007/s12035-013-8478-7, 23771815
-
Rasool S, Martinez-Coria H, Milton S, Glabe CG. Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice. Mol Neurobiol 2013, 48:931-940. 10.1007/s12035-013-8478-7, 23771815.
-
(2013)
Mol Neurobiol
, vol.48
, pp. 931-940
-
-
Rasool, S.1
Martinez-Coria, H.2
Milton, S.3
Glabe, C.G.4
|